ACHV Stock Analysis: Buy, Sell, or Hold?
ACHV - Achieve Life Sciences, Inc.
$5.86
-0.10 (-1.68%)
▼
5d:
+22.34%
30d:
+65.07%
90d:
+41.89%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Distribution
ACHV is up 11.4% this week, but smart money is buying puts. Top strike: $2.5 2026-06-18 with 2 OI. Put ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When ACHV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ACHV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ACHV is 15.6% above its trading range ($5.07). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ACHV is 15.6% above its trading range ($5.07). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ACHV is currently trading at $5.86, which is considered extended relative to its 30-day fair value range of $3.54 to $5.07.
Technical Outlook: Technically, ACHV is in a downtrend. Immediate support is located at $4.20, while resistance sits at $6.15.
Market Sentiment: ACHV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.62 (+145.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACHV is in a downtrend. Immediate support is located at $4.20, while resistance sits at $6.15.
Market Sentiment: ACHV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.62 (+145.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.54 -
$5.07
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+15.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 145.4% below Wall St target ($14.62)
- WARNING: Recommendation downgraded due to 15.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$3.54 -
$5.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.20
Resistance Level
$6.15
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.02
Wall Street Target
$14.63
(+145.4%)
Share & Embed Analysis
Last updated: May 14, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACHV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 60 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 59 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 65 BUY |
